Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
02/2005
02/10/2005US20050032187 Novel peptide-forming enzyme, microbe producing the enzyme and method for producing peptide using them
02/10/2005US20050032185 3-phosphoinositide-dependent protein kinase that phosphorylates and activates protein kinase B alpha; drug target for cancer; drug screening for enzyme inhibitors as anticancer agents
02/10/2005US20050032184 Disorazole polyketide synthase encoding polynucleotides
02/10/2005US20050032176 Modular polyketide synthases with altered activity
02/10/2005US20050032174 Multimeric protein for use in the treatment and prevention of infection and bleeding disorders
02/10/2005US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia
02/10/2005US20050032169 Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity
02/10/2005US20050032168 17 human secreted proteins
02/10/2005US20050032161 Novel xanthine phosphoribosyl transferase
02/10/2005US20050032160 Cell-based therapies for diabetes mellitus and other glucose intolerant states
02/10/2005US20050032157 Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof
02/10/2005US20050032156 Identification and characterization of phosphate transporter genes
02/10/2005US20050032154 Using microbial enzyme mixture to generate tripeptides for use in pharmaceuticals and foods
02/10/2005US20050032152 Using glucanases and glycosidase mixture to degrade heteropolysaccharide polymers associated with subterranean well digging and personal care products
02/10/2005US20050032146 Tssk4: a human testis specific serine/threonine kinase
02/10/2005US20050032145 Spectrophotometric assay; incubating a mixture of said amidotransferase, fructose 6-phosphate, and glutamine to form glutamine-6-phosphate, acetylating to to form N-acetylglucosamine, reacting with Ehrlich's reagent, measuring optical density; use in high throughput microtiter plate analysis
02/10/2005US20050032144 Method for selective conjugation of analytes to enzymes without unwanted enzyme-enzyme cross-linking
02/10/2005US20050032123 Oncoprotein protein kinase
02/10/2005US20050032119 drug design; models; computer analysis
02/10/2005US20050032109 Polypeptide activator for use as tool in treatment of thrombosis; treatment diagnosis of blood disorders
02/10/2005US20050032098 Human SCAD family molecules
02/10/2005US20050032094 Promoter sequences for specialized polymerase for use in diagnosis, prevention and treatment of cell proliferative and aging disorders
02/10/2005US20050032087 Using receptor-type protein tyrosine phosphatase (RPTP) as diagnostic tools in identifying modulators for treatment and prevention of cell proliferative disorders
02/10/2005US20050032086 Providing cell-free system for use in vitro translation and/or transcription
02/10/2005US20050032070 Polymorphisms in the human gene for CYP2D6 and their use in diagnostic and therapeutic applications
02/10/2005US20050032059 Genetically modified hydrolase comprising enhanced activity for use in hydrolysis of starch to glucose; textile treatment; preparation of animal feeds
02/10/2005US20050032054 Screening for novel bioactivities
02/10/2005US20050032047 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay
02/10/2005US20050032043 Recombinant negative strand RNA virus expression systems and vaccines
02/10/2005US20050031701 Matrix granule
02/10/2005US20050031607 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
02/10/2005US20050031604 Secreted by serpent venom glands; endogenous vasopeptidase inhibitors; angiotensin converting enzyme inhibitors; vasodilating and anti-hypertensive action; bradykinins; mass spectrometry
02/10/2005US20050031603 Obtainable from whey fraction of milk curd; centrifugation; ultrafiltration; lyophilization
02/10/2005US20050029191 Separation medium, its preparation and its use
02/10/2005CA2820028A1 Multimeric oxidoreductases
02/10/2005CA2537899A1 Tissue-specific targeting of therapeutic and imaging agents to caveolae
02/10/2005CA2534275A1 Pichia methanolica secretory signal
02/10/2005CA2533938A1 Multimeric oxidoreductases
02/10/2005CA2533936A1 Metabolically engineered bacterial strains having enhanced 2-keto-d-gluconate accumulation
02/10/2005CA2533613A1 Method for the production of multiply-unsaturated fatty acids in transgenic organisms
02/10/2005CA2521284A1 Novel glyphosate-n-acetyltransferase (gat) genes
02/09/2005EP1505160A2 5'nucleases derived from thermostable DNA polymerase
02/09/2005EP1505155A1 Novel carbonyl reductase, gene thereof and use of the same
02/09/2005EP1505151A2 Directed evolution method
02/09/2005EP1505149A1 Methylotroph producing mammalian type sugar chain
02/09/2005EP1504368A2 Method for crystallizing human gsk3 and novel crystal structure thereof
02/09/2005EP1504122A2 Methods of identifying genes for the manipulation of triterpene saponins
02/09/2005EP1504117A2 Process for generating sequence-specific proteases by directed evolution and use thereof
02/09/2005EP1504109A1 Method for the production of lactic acid or a salt thereof by simultaneous saccharification and fermentation of starch
02/09/2005EP1504093A2 Rna detection enzymes
02/09/2005EP1504092A2 Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
02/09/2005EP1504091A2 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants
02/09/2005EP1504090A2 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors
02/09/2005EP1504026A2 Therapeutic polypeptides, nucleic acids encodings same, and methods of use
02/09/2005EP1504023A2 Recombinant glycosyltransferase fusion proteins
02/09/2005EP1503985A2 Polypeptides and biosynthetic pathways
02/09/2005EP1503789A2 Vascularization enhanced graft constructs
02/09/2005EP1503749A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof
02/09/2005EP1327143A4 Crystal structure of bace and uses thereof
02/09/2005EP1282633A4 Mammalian soluble adenylyl cyclase
02/09/2005EP1274980A4 Solution and crystal structures of mmp-13 active site and uses thereof
02/09/2005EP1255850A4 AMPLIFICATION OF $i(CYP24) AND USES THEREOF
02/09/2005EP1082875A4 Improved brush block housing for propeller deicing system
02/09/2005EP1009805A4 TRANSGENIC PLANTS OF ALTERED MORPHOLOGY AND THE ISOLATED $i(ARABIDOPSIS THALIANA) ENDO-1,4-$g(b)-GLUCANASE GENE, PROMOTER AND PROTEIN
02/09/2005EP0975708B1 Methods and materials for degrading xanthan
02/09/2005EP0843818B1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
02/09/2005EP0828755A4 Method for molecular cloning and polynucleotide synthesis using vaccinia dna topoisomerase
02/09/2005EP0365597B2 Improved processes for the treatment of vascular disease
02/09/2005CN1578840A Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes
02/09/2005CN1578839A Modulating urea degradation in wine yeast
02/09/2005CN1578836A Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
02/09/2005CN1578835A Aromatic methyltransferases and uses thereof
02/09/2005CN1578833A Materials and methods for reducing oxalate concentrations in fluids
02/09/2005CN1578832A Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants
02/09/2005CN1578831A Fungal micro-organism having an increased ability to carry out biotechnological process(es)
02/09/2005CN1578663A Inhibitors of histone deacetylase
02/09/2005CN1576369A Prawn leukasmus rhabdovirus dUTPase gene and coded polypeptide thereof
02/09/2005CN1576365A 葡萄糖脱氢酶 Glucose dehydrogenase
02/09/2005CN1575816A Compounds for the treatment of female sexual dysfunction
02/09/2005CN1188522C Target thrombolytic protein expressing plasmid for thrombus and its construction
02/09/2005CN1188521C Coding of gene of protein with synthetic aurone activity
02/09/2005CN1188520C Production of polyketies in plants
02/09/2005CN1188518C Enzyme stabilization by cationic surfactants
02/09/2005CN1188517C Method of purifying thrombin-like protease enzymes obtained from snake venom
02/09/2005CN1188516C Coded nucleotide sequence of recombinant nattokinase and process for producing the same nattokinase
02/08/2005US6852910 Plant recombination proteins
02/08/2005US6852909 Process for producing female-sterile plants
02/08/2005US6852838 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders
02/08/2005US6852834 Fusion peptides isolatable by phase transition
02/08/2005US6852833 Artificial chaperon kit
02/08/2005US6852744 Pyrrolidine derivatives and their use as chymase inhibitor
02/08/2005US6852686 Methods for ameliorating icthyosiform skin diseases
02/08/2005US6852530 Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
02/08/2005US6852521 Comprises nucleotide sequences coding enzymatic polypeptides for use as drug screening, diagnostic and therapeutic tools; cosmetics; nutriceuticals
02/08/2005US6852520 DSP-2 dual-specificity phosphatase
02/08/2005US6852519 MAP/extracellular signal-regulated kinases which effect protein phosphorylation; biochips
02/08/2005US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6
02/08/2005US6852517 Useful as feedstock for polymers; comprises glycerol dehydratase/ aldehyde dehydrogenase; escherichia
02/08/2005US6852514 Hyaluronate synthase gene and uses thereof
02/08/2005US6852512 Expression vectors for production of foreign proteins as soluble forms